Prognostic significance of minimal residual disease (MRD) in children with high risk acute lymphoblastic leukemia(ALL). A children's oncology group study.

被引：1
|
作者：
Borowitz, MJ
Devidas, M
Bowman, WP
Larsen, E
Pullen, J
Camitta, B
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD USA
[2] Childrens Oncol Grp, Ctr Data, Gainesville, FL USA
[3] Cook Childrens Hosp, Ft Worth, TX USA
[4] Maine Childrens Canc Program, Scarborough, ME USA
[5] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA
[6] Midw Childrens Canc Ctr, Milwaukee, WI USA
[7] Childrens Oncol Grp, Arcadia, CA USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.85.85
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
85
引用
收藏
页码：29A / 29A
页数：1
相关论文
共 50 条
  • [41] Prognostic value of minimal residual disease (MRD) in childhood acute lymphoblastic leukemia (ALL) using polymerase chain reaction (PCR)
    Katsibardi, K.
    Palathanasiou, C.
    Moschovi, M.
    Karamolegou, K.
    Lambrou, G. I.
    Tzortzatou-Stathopoulou, F.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (03) : 387 - 387
  • [42] Definition of molecular remission in adult acute lymphoblastic leukemia (ALL) based on minimal residual disease (MRD)
    Goekbuget, N.
    Brueggemann, M.
    Arnold, R.
    Bartram, C-R
    Fietkau, R.
    Freund, M.
    Ganser, A.
    Kneba, M.
    Lipp, T.
    Ludwig, W-D
    Maschmeyer, G.
    Messerer, D.
    Raff, T.
    Rieder, H.
    Serve, H.
    Thiel, E.
    Hoelzer, D.
    ONKOLOGIE, 2010, 33 : 213 - 213
  • [43] ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - DETECTION OF MINIMAL RESIDUAL DISEASE (MRD) AT FLOW-CYTOMETRY
    ORFAO, A
    CIUDAD, J
    LOPEZBERGES, MC
    LOPEZ, A
    VIDRIALES, B
    CABALLERO, MD
    VALVERDE, B
    GONZALEZ, M
    SANMIGUEL, JF
    LEUKEMIA & LYMPHOMA, 1994, 13 : 87 - 90
  • [44] DOES ERYTHROBLASTIC RECOVERY REFLECT ABSENCE OF MINIMAL RESIDUAL DISEASE (MRD) IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)?
    Ikoma, Maura R. V.
    Souza, Marina M. O.
    Penitenti, Marcimara
    Souza, Mair P.
    Colturato, Vergilio A. R.
    Oliveira, Claudia T.
    Pedro, Andrea M.
    Mattos, Ederson R.
    Mauad, Marcos A.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2008, 74B (06) : 371 - 371
  • [45] Comparison of Immunophenotypic Abnormalities in B-Lymphoblastic Leukemia (B-ALL) Minimal Residual Disease (MRD) of Adults and Children Utilizing the Children's Oncology Group (COG)-Validated Multiparameter Flow Cytometry (MFC)-MRD Approach: An Institutional Experience
    Abro, Brooj
    Shirai, Cara Lunn
    Hassan, Anjum
    Kudlinski, Yvette
    Weddle, Barbara
    Kreisel, Friederike
    BLOOD, 2018, 132
  • [46] Immunological detection of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL): A prospective study in 106 patients.
    Lucio, P
    Silva, M
    Faria, T
    Dias, I
    Santos, A
    Santos, I
    Parreira, A
    BLOOD, 2001, 98 (11) : 459A - 460A
  • [47] Minimal residual disease in early phase of chemotherapy reflects poor outcome in children with acute lymphoblastic leukemia - A retrospective study by the Children's Cancer and Leukemia Study Group in Japan
    Okamoto, T
    Yokota, S
    Katano, N
    Seriu, T
    Nakao, M
    Taniwaki, M
    Watanabe, A
    Asami, K
    Kikuta, A
    Koizumi, S
    Kawakami, T
    Ohta, S
    Miyake, M
    Watanabe, T
    Iwai, A
    Kamitamari, A
    Ijichi, O
    Hyakuna, N
    Mimaya, J
    Fujimoto, T
    Tsurusawa, M
    LEUKEMIA & LYMPHOMA, 2002, 43 (05) : 1001 - 1006
  • [48] Allergic reactions and antiasparaginase antibodies in children with high-risk acute lymphoblastic leukemia: A children's oncology group report
    Ko, Richard H.
    Jones, Tamekia L.
    Radvinsky, David
    Robison, Nathan
    Gaynon, Paul S.
    Panosyan, Eduard H.
    Avramis, Ioannis A.
    Avramis, Vassilios I.
    Rubin, Joan
    Ettinger, Lawrence J.
    Seibel, Nita L.
    Dhall, Girish
    CANCER, 2015, 121 (23) : 4205 - 4211
  • [49] Minimal residual disease in acute myeloid leukemia in children: MRD-AML-BFM 98 working group
    Griesinger, F
    Langebrake, C
    Dworzak, M
    Hrusak, O
    Viehmann, S
    Creutzig, U
    Harbott, J
    Reinhardt, D
    BLOOD, 2001, 98 (11) : 584A - 584A
  • [50] Measurable Residual Disease Detection in B-Acute Lymphoblastic Leukemia: The Children's Oncology Group (COG) Method
    Borowitz, Michael J.
    Wood, Brent L.
    Keeney, Michael
    Hedley, Benjamin D.
    CURRENT PROTOCOLS, 2022, 2 (03):
12345